Get the Stockscreener App
3.07
4.07%
0.12
Pre-market:
3.66
0.59
+19.22%
22nd Century Group, Inc. stock is traded at $3.07, with a volume of 218.82K.
It is up +4.07% in the last 24 hours and down -55.44% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$2.95
Open:
$2.95
24h Volume:
218.82K
Relative Volume:
0.29
Market Cap:
$1.54M
Revenue:
$29.78M
Net Income/Loss:
$-39.94M
P/E Ratio:
-0.0496
EPS:
-61.9139
Net Cash Flow:
$-16.12M
1W Performance:
-21.48%
1M Performance:
-55.44%
6M Performance:
-38.72%
1Y Performance:
-96.84%
1-Day Range:
$2.86
$3.114
1-Week Range:
$2.86
$3.9836
52-Week Range:
$0.432
$105.68
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
3.07 | 1.01M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
What catalysts could drive 22nd Century Group Inc. stock higher in 2025Get exclusive market insights for better trading - jammulinksnews.com
Is 22nd Century Group Inc. a growth stock or a value stockFree Trading Strategy Suggestions - jammulinksnews.com
22nd Century Group Inc. Stock Performance After Earnings: Historical InsightsFree AI-Powered Stock Predictions - beatles.ru
Why 22nd Century Group Inc. stock attracts strong analyst attentionFree Stock Market Insider Analysis - Metal.it
How 22nd Century Group Inc. stock performs during market volatilityTrade Ready Signal - Metal.it
Should I buy 22nd Century Group Inc. stock before earningsUnprecedented profits - jammulinksnews.com
VLN Commercial Launches Confirm Viability of the FDA's Proposed Reduced Nicotine Mandate - ADVFN Brasil
What drives 22nd Century Group Inc. stock priceSkyrocketing investment returns - PrintWeekIndia
Is 22nd Century Group Inc. a good long term investmentAccelerated financial growth - Autocar Professional
What analysts say about 22nd Century Group Inc. stockExplosive wealth accumulation - jammulinksnews.com
22nd Century Group Inc. Stock Analysis and ForecastTremendous financial leverage - Autocar Professional
22nd Century Group Expands VLN Cigarette Sales Across U.S. - Tobacco Reporter
Why Did 22nd Century Group Drop 10.18% Despite FDA Approval? - AInvest
22nd Century Group hopes new reduced nicotine cigarette resonates with smokers - Greensboro News and Record
22nd Century Surges to 480th in Trading Volume with 1932% Spike Amid Major Acquisition - AInvest
XXII Secures Broader State Approvals for Product Sales Expansion - GuruFocus
22nd Century Reports Expanded State Authorization Progress to Se - GuruFocus
22nd Century Reports Expanded State Authorization Progress to Sell VLN®, Partner VLN® and Conventional Products - The Globe and Mail
22nd Century Group’s Nicotine-Reduction Progress Accelerates Market Growth - StocksToTrade
22nd Century Group shares surge 56.11% intraday after expanding VLN® low-nicotine cigarette partnerships and meeting FDA's proposed nicotine limit. - AInvest
22nd Century Group Stock Soars as FDA’s Nicotine Crackdown Sparks Opportunity - RagingBull
22nd Century Stocks: Growth or Bubble? - timothysykes.com
Why Is 22nd Century Stock (XXII) Up 85% Today? - TipRanks
22nd Century Group (XXII) Stock Soars 110.04% on FDA Compliance - AInvest
22nd Century Group Stock Jumps 75% After Hour On News Of Reduced-Nicotine Push - Benzinga
22nd Century Group stock soars after expanding VLN cigarette partnerships - Investing.com
Tobacco brands partner with 22nd Century to expand reduced nicotine cigarettes By Investing.com - Investing.com South Africa
Tobacco brands partner with 22nd Century to expand reduced nicotine cigarettes - Investing.com Nigeria
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.97%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):